Phenolsulphotransferase

Enzyme activity and endogenous inhibitors in the human erythrocyte

Robert J. Anderson, R. M. Weinshilboum

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

PST (E.C. 2.8.2.1) plays an important role in the metabolism of many drugs catecholamine metabolites, and catecholamines. PST activity was detected in each of 178 human RBC lysates. When MHPG was used as a substrate, the activity ranged from 28 to 1385 U/ml of RBC, with an average value of 217.7 ± 13.1 (mean ± S.E.M.). However, there was not a direct relationship between quantity of RBC lysate and enzyme activity, an observation that raised the possibility of endogenous enzyme inhibitors. Therefore human RBC PST was partially purified (415-fold) to use in the study of tissue enzyme inhibitors. The pH optimum of the partially purified enzyme was 7.5, with an apparent Km value for [35S]PAPS of 0.46 μM and an apparent Km value for MHPG of 260 μM. When the partially purified enzyme was added to each of 20 human RBC lysates, its activity was inhibited an average of 91% ± 0.6 (mean ± S.E.M.). Endogenous inhibitors were also present in homogenates of human renal cortex and in homogenates of a variety of rat tissues. RBC lysates contained at least two PST inhibitors: a low-molecular-weight inhibitor (<2000) that was heat-, acid-, and base-stable, dialyzable, and resistant to digestion by chymotrypsin; and a high-molecular-weight inhibitor (> 65,000) that was heat-labile and nondialyzable. Whether the RBC enzyme activity may serve as an indicator of PST activity in less accessible tissues remains to be determined. However, the first-step toward testing this hypothesis will require the accurate measurement of PST activity in tissue preparations by a procedure that removes or inactivates enzyme inhibitors.

Original languageEnglish
Pages (from-to)158-171
Number of pages14
JournalThe Journal of Laboratory and Clinical Medicine
Volume94
Issue number1
StatePublished - 1979
Externally publishedYes

Fingerprint

Enzyme activity
Enzyme Inhibitors
Erythrocytes
Methoxyhydroxyphenylglycol
Tissue
Enzymes
Catecholamines
Scanning electron microscopy
Metabolites
Metabolism
Rats
Hot Temperature
Molecular Weight
Molecular weight
Observation
Kidney
Testing
Substrates
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Medicine(all)
  • Pathology and Forensic Medicine

Cite this

Phenolsulphotransferase : Enzyme activity and endogenous inhibitors in the human erythrocyte. / Anderson, Robert J.; Weinshilboum, R. M.

In: The Journal of Laboratory and Clinical Medicine, Vol. 94, No. 1, 1979, p. 158-171.

Research output: Contribution to journalArticle

@article{206064c736e74fa59671bedfab2df0dc,
title = "Phenolsulphotransferase: Enzyme activity and endogenous inhibitors in the human erythrocyte",
abstract = "PST (E.C. 2.8.2.1) plays an important role in the metabolism of many drugs catecholamine metabolites, and catecholamines. PST activity was detected in each of 178 human RBC lysates. When MHPG was used as a substrate, the activity ranged from 28 to 1385 U/ml of RBC, with an average value of 217.7 ± 13.1 (mean ± S.E.M.). However, there was not a direct relationship between quantity of RBC lysate and enzyme activity, an observation that raised the possibility of endogenous enzyme inhibitors. Therefore human RBC PST was partially purified (415-fold) to use in the study of tissue enzyme inhibitors. The pH optimum of the partially purified enzyme was 7.5, with an apparent Km value for [35S]PAPS of 0.46 μM and an apparent Km value for MHPG of 260 μM. When the partially purified enzyme was added to each of 20 human RBC lysates, its activity was inhibited an average of 91{\%} ± 0.6 (mean ± S.E.M.). Endogenous inhibitors were also present in homogenates of human renal cortex and in homogenates of a variety of rat tissues. RBC lysates contained at least two PST inhibitors: a low-molecular-weight inhibitor (<2000) that was heat-, acid-, and base-stable, dialyzable, and resistant to digestion by chymotrypsin; and a high-molecular-weight inhibitor (> 65,000) that was heat-labile and nondialyzable. Whether the RBC enzyme activity may serve as an indicator of PST activity in less accessible tissues remains to be determined. However, the first-step toward testing this hypothesis will require the accurate measurement of PST activity in tissue preparations by a procedure that removes or inactivates enzyme inhibitors.",
author = "Anderson, {Robert J.} and Weinshilboum, {R. M.}",
year = "1979",
language = "English",
volume = "94",
pages = "158--171",
journal = "Translational Research",
issn = "1931-5244",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Phenolsulphotransferase

T2 - Enzyme activity and endogenous inhibitors in the human erythrocyte

AU - Anderson, Robert J.

AU - Weinshilboum, R. M.

PY - 1979

Y1 - 1979

N2 - PST (E.C. 2.8.2.1) plays an important role in the metabolism of many drugs catecholamine metabolites, and catecholamines. PST activity was detected in each of 178 human RBC lysates. When MHPG was used as a substrate, the activity ranged from 28 to 1385 U/ml of RBC, with an average value of 217.7 ± 13.1 (mean ± S.E.M.). However, there was not a direct relationship between quantity of RBC lysate and enzyme activity, an observation that raised the possibility of endogenous enzyme inhibitors. Therefore human RBC PST was partially purified (415-fold) to use in the study of tissue enzyme inhibitors. The pH optimum of the partially purified enzyme was 7.5, with an apparent Km value for [35S]PAPS of 0.46 μM and an apparent Km value for MHPG of 260 μM. When the partially purified enzyme was added to each of 20 human RBC lysates, its activity was inhibited an average of 91% ± 0.6 (mean ± S.E.M.). Endogenous inhibitors were also present in homogenates of human renal cortex and in homogenates of a variety of rat tissues. RBC lysates contained at least two PST inhibitors: a low-molecular-weight inhibitor (<2000) that was heat-, acid-, and base-stable, dialyzable, and resistant to digestion by chymotrypsin; and a high-molecular-weight inhibitor (> 65,000) that was heat-labile and nondialyzable. Whether the RBC enzyme activity may serve as an indicator of PST activity in less accessible tissues remains to be determined. However, the first-step toward testing this hypothesis will require the accurate measurement of PST activity in tissue preparations by a procedure that removes or inactivates enzyme inhibitors.

AB - PST (E.C. 2.8.2.1) plays an important role in the metabolism of many drugs catecholamine metabolites, and catecholamines. PST activity was detected in each of 178 human RBC lysates. When MHPG was used as a substrate, the activity ranged from 28 to 1385 U/ml of RBC, with an average value of 217.7 ± 13.1 (mean ± S.E.M.). However, there was not a direct relationship between quantity of RBC lysate and enzyme activity, an observation that raised the possibility of endogenous enzyme inhibitors. Therefore human RBC PST was partially purified (415-fold) to use in the study of tissue enzyme inhibitors. The pH optimum of the partially purified enzyme was 7.5, with an apparent Km value for [35S]PAPS of 0.46 μM and an apparent Km value for MHPG of 260 μM. When the partially purified enzyme was added to each of 20 human RBC lysates, its activity was inhibited an average of 91% ± 0.6 (mean ± S.E.M.). Endogenous inhibitors were also present in homogenates of human renal cortex and in homogenates of a variety of rat tissues. RBC lysates contained at least two PST inhibitors: a low-molecular-weight inhibitor (<2000) that was heat-, acid-, and base-stable, dialyzable, and resistant to digestion by chymotrypsin; and a high-molecular-weight inhibitor (> 65,000) that was heat-labile and nondialyzable. Whether the RBC enzyme activity may serve as an indicator of PST activity in less accessible tissues remains to be determined. However, the first-step toward testing this hypothesis will require the accurate measurement of PST activity in tissue preparations by a procedure that removes or inactivates enzyme inhibitors.

UR - http://www.scopus.com/inward/record.url?scp=0018695199&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018695199&partnerID=8YFLogxK

M3 - Article

VL - 94

SP - 158

EP - 171

JO - Translational Research

JF - Translational Research

SN - 1931-5244

IS - 1

ER -